Grace Therapeutics Stock Forward View - Price Action Indicator
| GRCE Stock | 3.48 0.20 5.43% |
Grace Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Grace Therapeutics stock prices and determine the direction of Grace Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Grace Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Grace Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.39) | EPS Estimate Current Year (1.26) | EPS Estimate Next Year (1.28) | Wall Street Target Price 12.0858 | EPS Estimate Current Quarter (0.34) |
Using Grace Therapeutics hype-based prediction, you can estimate the value of Grace Therapeutics from the perspective of Grace Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Grace Therapeutics after-hype prediction price | USD 3.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Grace Therapeutics to cross-verify your projections. Grace Therapeutics Additional Predictive Modules
Most predictive techniques to examine Grace price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Grace using various technical indicators. When you analyze Grace charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.04) | (0.22) |
| Check Grace Therapeutics Volatility | Backtest Grace Therapeutics | Information Ratio |
Grace Therapeutics Trading Date Momentum
| On February 05 2026 Grace Therapeutics was traded for 3.48 at the closing time. The top price for the day was 3.74 and the lowest listed price was 3.45 . The trading volume for the day was 91.8 K. The trading history from February 5, 2026 did not cause price change. The overall trading delta against the current closing price is 6.90% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Grace Therapeutics to competition |
Other Forecasting Options for Grace Therapeutics
For every potential investor in Grace, whether a beginner or expert, Grace Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Grace Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Grace. Basic forecasting techniques help filter out the noise by identifying Grace Therapeutics' price trends.Grace Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Grace Therapeutics stock to make a market-neutral strategy. Peer analysis of Grace Therapeutics could also be used in its relative valuation, which is a method of valuing Grace Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Grace Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Grace Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Grace Therapeutics shares will generate the highest return on investment. By undertsting and applying Grace Therapeutics stock market strength indicators, traders can identify Grace Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 7119.42 | |||
| Daily Balance Of Power | (0.69) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 3.6 | |||
| Day Typical Price | 3.56 | |||
| Price Action Indicator | (0.22) | |||
| Period Momentum Indicator | (0.20) |
Grace Therapeutics Risk Indicators
The analysis of Grace Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Grace Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting grace stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.75 | |||
| Semi Deviation | 1.8 | |||
| Standard Deviation | 2.25 | |||
| Variance | 5.05 | |||
| Downside Variance | 4.21 | |||
| Semi Variance | 3.24 | |||
| Expected Short fall | (2.17) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Grace Therapeutics
The number of cover stories for Grace Therapeutics depends on current market conditions and Grace Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Grace Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Grace Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Grace Therapeutics Short Properties
Grace Therapeutics' future price predictability will typically decrease when Grace Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Grace Therapeutics often depends not only on the future outlook of the potential Grace Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Grace Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.1 M | |
| Cash And Short Term Investments | 22.1 M |
Check out Historical Fundamental Analysis of Grace Therapeutics to cross-verify your projections. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Pharmaceuticals sector continue expanding? Could Grace diversify its offerings? Factors like these will boost the valuation of Grace Therapeutics. Market participants price Grace higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Grace Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Grace Therapeutics requires distinguishing between market price and book value, where the latter reflects Grace's accounting equity. The concept of intrinsic value - what Grace Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Grace Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Grace Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Grace Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.